Press Resease

Wearable Injectors Market - Global Industry Analysis

Wearable Injectors Market by Type (Off-Body Injectors and On-Body Injectors), by Therapeutic Application (Cardiovascular Diseases, Diabetes, Immuno-Oncology, and Others), and by End-User (Home Care Settings, Clinics, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 11-Mar-2019 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3146 Status : Published

Global wearable injectors market expected to generate around USD 11.7 billion by 2025, at a CAGR of around 11.2% between 2019 and 2025. Wearable injectors are easy to use and convenient drug delivery devices that adhere to the body to subcutaneously administer the drug for a prolonged time period.

Description

The report covers a forecast and an analysis of the wearable injectors market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the wearable injectors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the wearable injectors market on a global and regional level.

In order to give the users of this report a comprehensive view of the wearable injectors market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the wearable injectors market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the wearable injectors market on a global and regional basis. 

Global Wearable Injectors Market

The study provides a decisive view of the wearable injectors market based on type, therapeutic application, end-user, and region. By type, the market is segmented into off-body injectors and on-body injectors. By therapeutic application, the market is segmented into cardiovascular diseases, diabetes, immuno-oncology, and others. Home care settings, clinics, hospitals, and others form the end-user segment of the wearable injectors market.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global wearable injectors market include Medtronic PLC, Amgen, Ypsomed, Tandem Diabetes Care, Inc., Insulet Corporation, Becton, Dickinson, and Company, Valeritas, Inc., United Therapeutics Corporation, SteadyMed Therapeutics, Enable Injections, and Sensile Medical.

This report segments the global wearable injectors market as follows:

Global Wearable Injectors Market: By Type

  • On-Body Injectors
  • Off-Body Injectors

Global Wearable Injectors Market: By Application

  • Immuno-Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Others

Global Wearable Injectors Market: By End-User

  • Hospitals
  • Clinics
  • Home Care Settings
  • Others

Global Wearable Injectors Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Wearable Injectors Market Revenue, 2016-2025 (USD Billion)
    • 2.2. Global Wearable Injectors Market: Snapshot
  •  
  • Chapter 3. Wearable Injectors Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Wearable Injectors Market drivers: Impact analysis
      • 3.2.2. Increasing Prevalence of Chronic Disorders
      • 3.2.3. Technological Advancements
    • 3.3. Market Restraints
      • 3.3.1. Preference for Alternative Drug Delivery Modes
    • 3.4. Opportunities
      • 3.4.1. Increasing Demand for Biologics and mAbs
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Type
      • 3.6.2. Market attractiveness analysis, by Therapeutic Application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Wearable Injectors Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Wearable Injectors Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Wearable Injectors Market - Type Analysis
    • 5.1. Global Wearable Injectors Market: Type overview
      • 5.1.1. Global Wearable Injectors Market revenue share, by Type, 2018 and 2025
    • 5.2. On-body injectors
      • 5.2.1. Global Wearable Injectors Market for On-body injectors, 2016-2025 (USD Billion)
    • 5.3. Off-body injectors
      • 5.3.1. Global Wearable Injectors Market for Off-body injectors, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Wearable Injectors Market - Therapeutic Application Analysis
    • 6.1. Global Wearable Injectors Market: Therapeutic Application segment overview
      • 6.1.1. Global Wearable Injectors Market revenue share, by Therapeutic Application, 2018 and 2025
    • 6.2. Immuno-oncology
      • 6.2.1. Global Wearable Injectors Market for Immuno-oncology, 2016-2025 (USD Billion)
    • 6.3. Diabetes
      • 6.3.1. Global Wearable Injectors Market for Diabetes, 2016-2025 (USD Billion)
    • 6.4. Cardiovascular Diseases
      • 6.4.1. Global Wearable Injectors Market for Cardiovascular Diseases, 2016-2025 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global Wearable Injectors Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Wearable Injectors Market - End-User Analysis
    • 7.1. Global Wearable Injectors Market: End-User overview
      • 7.1.1. Global Wearable Injectors Market revenue share, by End-User, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Wearable Injectors Market for Hospitals, 2016-2025 (USD Billion)
    • 7.3. Clinics
      • 7.3.1. Global Wearable Injectors Market for Clinics, 2016-2025 (USD Billion)
    • 7.4. Home Care Settings
      • 7.4.1. Global Wearable Injectors Market for Home Care Settings, 2016-2025 (USD Billion)
    • 7.5. Others
      • 7.5.1. Global Wearable Injectors Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Wearable Injectors Market - Regional Analysis
    • 8.1. Global Wearable Injectors Market: Regional overview
      • 8.1.1. Global Wearable Injectors Market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
      • 8.2.2. North America Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
      • 8.2.3. North America Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.2.4.2. The U.S. Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.2.4.3. The U.S. Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.2.5.2. Rest of North America Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.2.5.3. Rest of North America Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
      • 8.3.2. Europe Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
      • 8.3.3. Europe Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.3.4.2. Germany Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.3.4.3. Germany Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.3.5.2. UK Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.3.5.3. UK Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.3.6.2. France Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.3.6.3. France Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.4.4.2. China Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.4.4.3. China Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.4.5.2. Japan Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.4.5.3. Japan Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.4.6.2. India Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.4.6.3. India Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
      • 8.5.2. Latin America Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
      • 8.5.3. Latin America Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.5.4.2. Brazil Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.5.4.3. Brazil Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Wearable Injectors Market revenue, by Type, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Wearable Injectors Market revenue, by Therapeutic Application, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Wearable Injectors Market revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Amgen
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Medtronic PLC
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Insulet Corporation
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Ypsomed
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Becton, Dickinson, and Company
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Tandem Diabetes Care, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. United Therapeutics Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Valeritas, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Enable Injections
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. SteadyMed Therapeutics
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. Sensile Medical
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product Portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments

Methodology

Free Analysis

Wearable injectors are drug delivery devices that are also called patch injectors or patch pumps. Drug delivery devices help to reduce the dependence on healthcare providers and lower the number of hospital visits. They also help in enhancing treatment adherence to one’s therapeutic dose regimen. Multiple injections can be avoided using wearable injectors. Wearable injectors are easy to use and offer convenience to the patients. Wearable injectors safely deliver drugs faster and are ideal for viscous, large volume drugs, which can be used for cancer, diabetes, and cardiovascular disease treatment.

The growing prevalence of chronic disorders worldwide, such as diabetes, cancer, cardiovascular diseases, etc., technological advancements in wearable injectors design, increasing investments made by major players, and favorable reimbursement policies for wearable injectors are major factors contributing to the global wearable injectors market. Additionally, the growing preference for wearable injectors to avoid needlestick injuries caused by traditional injectors, large-scale adoption of wearable injectors, and continuous increase in the development of biologics will further propel the wearable injectors market globally. However, the high cost and availability of alternative drug delivery systems may the hamper wearable injectors market. The growing demand for biologics and monoclonal antibodies are likely to bring new growth opportunities in the wearable injectors market in the future.

Global Wearable Injectors Market

The global wearable injectors market is segmented based on type, therapeutic application, and end-user. By type, the market is segmented into off-body injectors and on-body injectors. Skin sensitivity, painful removal, and irritation associated with on-body injectors are fuelling the adoption of off-body injectors.

By therapeutic application, the market is segmented into cardiovascular diseases, diabetes, immuno-oncology, and others. The immuno-oncology segment held the largest market share in 2018, due to the growing prevalence of cancer and increase cancer awareness. The diabetes segment will show the highest CAGR in the upcoming years, owing to the increasing diabetes prevalence worldwide and rising use of insulin and insulin analogs by diabetes patients.

Home care settings, clinics, hospitals, and others form the end-user segment of the wearable injectors market. Hospitals held the largest market share in 2018, whereas home care settings are expected to register the highest growth in the future.

North America dominated the global wearable injectors market with a market share of about 42% in 2018 and is estimated to maintain its leading position over the forecast time period as well. This can be attributed to the increasing prevalence of chronic diseases, such as diabetes, cancer, cardiovascular diseases etc., the presence of major market players, favorable reimbursement policies for wearable injectors, developed healthcare infrastructure, and growing adoption of wearable injectors. Europe was the second largest region in 2018 in the global wearable injectors market, due to the developed healthcare infrastructure, favorable reimbursement policies, and growing adoption of technologically advanced therapies. Asia Pacific will witness the highest CAGR over the forecast time period in the wearable injectors market globally, owing to an increasingly aging population that is prone to suffering from chronic diseases, growing health awareness, and need for self-drug administration for diabetes, cardiovascular diseases, etc.

Some key players of the global wearable injectors market include Medtronic PLC, Amgen, Ypsomed, Tandem Diabetes Care, Inc., Insulet Corporation, Becton, Dickinson, and Company, Valeritas, Inc., United Therapeutics Corporation, SteadyMed Therapeutics, Enable Injections, and Sensile Medical.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social